RBC upgrades Sartorius on stronger outlook, AI opportunities

Sartorius AG

Today 09:25

** RBC upgrades German pharmaceutical equipment supplier Sartorius SATG.DE to "outperform" from "sector perform", citing an improving outlook, accelerating growth prospects and potential benefits from AI-driven demand
** The broker points to the company's raised guidance, supported by favourable foreign exchange trends as well as expectations for faster underlying growth in 2027
** AI is emerging as a demand driver across biopharma and academia, with Sartorius set to benefit through its LPS division and small-scale bioreactor range, RBC says
** Out of four analysts covering the stock, one rates it "strong buy", two "buy" and one "hold" - LSEG data 


($1 = 0.8919 euros)

 (Reporting by Conrad Kuepper)
 ((conrad.kuepper@thomsonreuters.com))